ClinVar Miner

Submissions for variant NM_000521.4(HEXB):c.512-1G>T

dbSNP: rs1554035308
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000673291 SCV000798475 likely pathogenic Sandhoff disease 2018-03-12 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000673291 SCV004037804 likely pathogenic Sandhoff disease 2023-08-31 criteria provided, single submitter clinical testing Variant summary: HEXB c.512-1G>T is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Three predict the variant abolishes a canonical 3' splicing acceptor site. These three tools also predict the variant creates or strengthens a cryptic 3' acceptor site 6 nucleotides downstream of the canonical site. At least one publication reports experimental evidence that this variant affects mRNA splicing, finding that a patient with the variant expresses transcripts lacking the first 6 nucleotides of exon 4, which is predicted to result in an in-frame deletion of the G171 and L172 residues (Zampieri_2008), located in the Beta-hexosaminidase, eukaryotic type, N-terminal domain (IPR029019) of the encoded protein. The variant was absent in 247230 control chromosomes (gnomAD). c.512-1G>T has been reported in the literature in an individual affected with Sandhoff Disease (Zampieri_2008). This patient was reported as compound heterozygous with another variant (c.299G>T) predicted to have a splicing impact, and RT-PCR and sequencing analysis did not find a transcript associated with this allele, indicating it produces an unstable transcript. These data suggest that c.512-1G>T is likely associated with disease. The following publication has been ascertained in the context of this evaluation (PMID: 18758829). One submitter has cited a clinical-significance assessment for this variant to ClinVar after 2014 and has classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.